Research map: Differential expression of growth differentiation factor 11 and growth differentiation factor 15 and their association with iron overload in β-thalassemia patients undergoing fetal hemoglobin induction or transfusion therapy

Back to the article

Papers in this map

  1. Beta-thalassemia · Renzo Galanello · 2010 · 1485 citations · Cited by this paper
  2. Clinical significance of aberrant expression of CD56 on newly diagnosed adult acute myeloid leukemia blast cells · 2025 · Related
  3. Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis · Rajasekhar N.V.S. Suragani · 2014 · 447 citations · Cited by this paper
  4. Epigenetic regulation of the TET2 gene in Iraqi patients with acute myeloid leukemia: Expression and methylation analysis · 2026 · Related
  5. Changing patterns in the epidemiology of β‐thalassemia · Antonis Kattamis · 2020 · 333 citations · Cited by this paper
  6. Interleukin-35-driven immune evasion in acute myeloid leukemia: Correlation with circulating (CD3+ CD56+) lymphocyte · 2025 · Related
  7. A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia · Maria Domenica Cappellini · 2020 · 329 citations · Cited by this paper
  8. Filgrastim-induced cutaneous vasculitis in a patient undergoing stem cell mobilization · 2025 · Related
  9. β-thalassemia distribution in the old world: a historical standpoint of an ancient disease · Vincenzo De Sanctis · 2017 · 280 citations · Cited by this paper
  10. Shorting of existing conditioning regimen for relapsed/refractory gastric diffuse large B-cell lymphoma transplant and studying its related outcomes: A first of its kind case report · 2025 · Related
  11. An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia · Michaël Dussiot · 2014 · 279 citations · Cited by this paper
  12. The risk of pulmonary hypertension in sickle cell disease in relation to the disease severity · 2025 · Related
  13. Erythropoiesis: insights into pathophysiology and treatments in 2017 · Andrea Zivot · 2018 · 165 citations · Cited by this paper
  14. Evaluation of the level of endothelin-1 and tumor necrosis factor-alpha in patients with sickle cell disease · 2026 · Related
  15. Complications of thalassemia major and their treatment · Caterina Borgna‐Pignatti · 2011 · 162 citations · Cited by this paper
  16. Advancement in thrombosis management: Three-dimensional bioprinting technology for precision anticoagulant dosing · 2025 · Related
  17. Transfusion complications in thalassemia patients: a report from the C enters for D isease C ontrol and P revention (CME) · Elliott P. Vichinsky · 2013 · 129 citations · Cited by this paper
  18. Investigating the role of red cell and platelet distribution width-to-platelet ratios in diagnosing early-onset neonatal sepsis · 2025 · Related
  19. An activin receptor II A ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin · Soraya Carrancio · 2014 · 123 citations · Cited by this paper
  20. Ineffective erythropoiesis and its treatment · Mario Cazzola · 2021 · 96 citations · Cited by this paper
  21. Role of growth differentiation factor 11 in development, physiology and disease · Yonghui Zhang · 2017 · 85 citations · Cited by this paper
  22. Safety and efficacy of thalidomide in patients with transfusion-dependent β-thalassemia: a randomized clinical trial · Jiangming Chen · 2021 · 46 citations · Cited by this paper
  23. Thalassemia in Pakistan · Sehar Khaliq · 2022 · 40 citations · Cited by this paper
  24. Regulation of erythropoiesis: emerging concepts and therapeutic implications · Pu Tang · 2023 · 32 citations · Cited by this paper
  25. The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells · Parin Rattananon · 2021 · 24 citations · Cited by this paper
  26. Evaluation of the combination therapy of hydroxyurea and thalidomide in β-thalassemia · Saqib Hussain Ansari · 2022 · 24 citations · Cited by this paper
  27. Evaluation of regulatory T cells frequency and FoxP3/GDF-15 gene expression in β-thalassemia major patients with and without alloantibody; correlation with serum ferritin and folate levels · Negin Shokrgozar · 2020 · 22 citations · Cited by this paper
  28. GDF11 contributes to hepatic hepcidin (HAMP) inhibition through SMURF1‐mediated BMP‐SMAD signalling suppression · Zheng Fang · 2019 · 22 citations · Cited by this paper
  29. Luspatercept for β-thalassemia: beyond red blood cell transfusions · Ali T. Taher · 2021 · 19 citations · Cited by this paper
  30. GDF11 is increased in patients with aplastic anemia · Xifeng Dong · 2019 · 17 citations · Cited by this paper
  31. The association between growth differentiation factor-15, erythroferrone, and iron status in thalassemic patients · Ilham Youssry · 2023 · 17 citations · Cited by this paper
  32. GDF11 is not the target of luspatercept · Clara Camaschella · 2019 · 15 citations · Cited by this paper
  33. GDF‐15 is associated with atherosclerosis in adults with transfusion‐dependent beta‐thalassemia · Alaa Efat · 2022 · 13 citations · Cited by this paper
  34. GDF-15 and hepcidin as a therapeutic target for anemia in chronic kidney disease · Naglaa Makram Farag · 2023 · 13 citations · Cited by this paper
  35. The effect of transfusion on immune responses in thalassemia · Marianna Politou · 2020 · 9 citations · Cited by this paper
  36. ACTIVIN RECEPTOR LIGAND FOR THR TREATMENT OF BETA-THALASSEMIA: a SERENDIPITOUS DISCOVERY · Irene Motta · 2020 · 9 citations · Cited by this paper
  37. Growth differentiation factor 15 as a marker of ineffective erythropoiesis in patients with chronic C virus infection · MohamedA Helwa · 2017 · 7 citations · Cited by this paper
  38. GDF11 Increased in Patients with Myelodysplastic Syndrome · Yu Han · 2015 · 6 citations · Cited by this paper

Source: OpenAlex (CC0)